317 related articles for article (PubMed ID: 16586052)
1. [Sentinel lymph node dissection in prostate cancer. Experience after more than 800 interventions].
Weckermann D; Hamm M; Dorn R; Wagner T; Wawroschek F; Harzmann R
Urologe A; 2006 Jun; 45(6):723-7. PubMed ID: 16586052
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.
Weckermann D; Dorn R; Trefz M; Wagner T; Wawroschek F; Harzmann R
J Urol; 2007 Mar; 177(3):916-20. PubMed ID: 17296375
[TBL] [Abstract][Full Text] [Related]
3. [Extended sentinel lymph node dissection in radical prostatectomy for prostate cancer: a study in the Kiel risk population].
Hautmann S; Beitz S; Naumann M; Lützen U; Seif C; Stübinger SH; van der Horst C; Braun PM; Leuschner I; Henze E; Jünemann KP
Urologe A; 2008 Mar; 47(3):299-303. PubMed ID: 18273596
[TBL] [Abstract][Full Text] [Related]
4. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
5. Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection.
Jeschke S; Nambirajan T; Leeb K; Ziegerhofer J; Sega W; Janetschek G
J Urol; 2005 Jun; 173(6):1943-6. PubMed ID: 15879787
[TBL] [Abstract][Full Text] [Related]
6. Limitations of radioguided surgery in high-risk prostate cancer.
Weckermann D; Dorn R; Holl G; Wagner T; Harzmann R
Eur Urol; 2007 Jun; 51(6):1549-56; discussion 1556-8. PubMed ID: 16996201
[TBL] [Abstract][Full Text] [Related]
7. Is a limited lymph node dissection an adequate staging procedure for prostate cancer?
Bader P; Burkhard FC; Markwalder R; Studer UE
J Urol; 2002 Aug; 168(2):514-8; discussion 518. PubMed ID: 12131300
[TBL] [Abstract][Full Text] [Related]
8. Simplified intraoperative sentinel-node detection performed by the urologist accurately determines lymph-node stage in prostate cancer.
Kjölhede H; Bratt O; Gudjonsson S; Sundqvist P; Liedberg F
Scand J Urol; 2015 Apr; 49(2):97-102. PubMed ID: 25331366
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer.
Jeschke S; Beri A; Grüll M; Ziegerhofer J; Prammer P; Leeb K; Sega W; Janetschek G
Eur Urol; 2008 Jan; 53(1):126-32. PubMed ID: 17434672
[TBL] [Abstract][Full Text] [Related]
10. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
Heidenreich A; Ohlmann CH
Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
[TBL] [Abstract][Full Text] [Related]
11. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
Arenas LF; Füllhase C; Boemans P; Fichtner J
Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
[TBL] [Abstract][Full Text] [Related]
12. Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging.
Jeschke S; Lusuardi L; Myatt A; Hruby S; Pirich C; Janetschek G
Urology; 2012 Nov; 80(5):1080-6. PubMed ID: 22990053
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node dissection in more than 1200 prostate cancer cases: rate and prediction of lymph node involvement depending on preoperative tumor characteristics.
Winter A; Kneib T; Henke RP; Wawroschek F
Int J Urol; 2014 Jan; 21(1):58-63. PubMed ID: 23659488
[TBL] [Abstract][Full Text] [Related]
14. Percentage of positive biopsies predicts lymph node involvement in men with low-risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomy.
Heidenreich A; Pfister D; Thüer D; Brehmer B
BJU Int; 2011 Jan; 107(2):220-5. PubMed ID: 20590538
[TBL] [Abstract][Full Text] [Related]
15. [Sentinel node dissection in prostate cancer: current status].
Weckermann D; Holl G; Wagner T; Harzmann R
Urologe A; 2007 Nov; 46(11):1500-7. PubMed ID: 17928984
[TBL] [Abstract][Full Text] [Related]
16. Novel staging tool for localized prostate cancer: a pilot study using genetic adaptive neural networks.
Tewari A; Narayan P
J Urol; 1998 Aug; 160(2):430-6. PubMed ID: 9679892
[TBL] [Abstract][Full Text] [Related]
17. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
Cagiannos I; Karakiewicz P; Eastham JA; Ohori M; Rabbani F; Gerigk C; Reuter V; Graefen M; Hammerer PG; Erbersdobler A; Huland H; Kupelian P; Klein E; Quinn DI; Henshall SM; Grygiel JJ; Sutherland RL; Stricker PD; Morash CG; Scardino PT; Kattan MW
J Urol; 2003 Nov; 170(5):1798-803. PubMed ID: 14532779
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence Guided Targeted Pelvic Lymph Node Dissection for Intermediate and High Risk Prostate Cancer.
Hruby S; Englberger C; Lusuardi L; Schätz T; Kunit T; Abdel-Aal AM; Hager M; Janetschek G
J Urol; 2015 Aug; 194(2):357-63. PubMed ID: 25896557
[TBL] [Abstract][Full Text] [Related]
19. Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.
Karam JA; Svatek RS; Karakiewicz PI; Gallina A; Roehrborn CG; Slawin KM; Shariat SF
Clin Cancer Res; 2008 Mar; 14(5):1418-22. PubMed ID: 18316564
[TBL] [Abstract][Full Text] [Related]
20. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection.
Häcker A; Jeschke S; Leeb K; Prammer K; Ziegerhofer J; Sega W; Langsteger W; Janetschek G
J Urol; 2006 Nov; 176(5):2014-8; discussion 2018-9. PubMed ID: 17070241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
